| 摘要 |
There is presented compounds of the formula <IMAGE> wherein A is selected from the group consisting of <IMAGE> +TR <IMAGE> R1 is selected from the group consisting of hydrogen, chlorine, bromine, lower alkyl, the group NR4R5, the group -CH2-CO-R7, the group-NH(CH2)mNR8R9, hydroxy, lower alkoxy, mercapto and lower alkyl mercapto; R2 is selected from the group consisting of hydrogen, amino and dilower alkyl amino; R3 is selected from the group consisting of hydrogen, lower acyloxy and hydroxy; X is selected from the group consisting of hydrogen, halogen, trifluoromethyl, ethyl, alpha -hydroxy ethyl and acetyl; Y is hydrogen or halogen; R4 and R5 are hydrogen or lower alkyl or together with their co-bonded nitrogen atom form a five to seven membered heterocyclic group; R7 is selected from the group consisting of hydroxy lower alkoxy and NR8R9; R8 and R9 are hydrogen or lower alkyl; n is 0 or 1 and m is 1 to 7 with the limitations that (1) at least one of R1 and R2 are hydrogen, (2) when R3 is lower acyloxy or hydroxy, A is the group (a), X is hydrogen, halogen, trifluoromethyl, ethyl or acetyl and R1 is the group -NH(CH2)mNR8R9, then R8 and R9 are lower alkyl, (3) when A is group (d) and R1 is the group -NH(CH2)mNR8R9 then R8 and R9 are lower alkyl and (4) when n is 1, R1 is hydrogen, lower alkyl, lower alkoxy, chlorine, bromine or the group -CH2-CO- R7 with R7 as above then A is the group (a) or (b) and the pharmaceutically acceptable salts thereof. The compounds exhibit pharmacological activity as anxiolytics and sedatives. Also presented Are various novel intermediates and processes to produce the above end products.
|
